Landmark China trial gets 84% efficacy in treating cancer with clue from waste water tech
For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientists are pointing to an unconventional therapeutic agent – the element iron. This idea originated in industrial waste water treatment: iron can react with hydrogen peroxide to generate hydroxyl radicals, which degrade various organic and toxic…
In a groundbreaking trial, Chinese scientists have discovered an 84% efficacy rate for treating advanced cancer using an unconventional therapeutic agent: iron. This discovery originated from industrial waste water treatment, where iron reacts with hydrogen peroxide to generate hydroxyl radicals that degrade organic and toxic molecules.
The scientists developed a nano-carbon iron injection called CNSI-Fe, combining iron with a nano-carbon injection to treat malignant tumors. In a first-of-its-kind trial, physicians injected the solution directly into the tumor sites of 19 patients with advanced cancer. Clinical follow-up showed that tumour growth stopped in 16 patients, with two experiencing tumour shrinkage.
The study, published in Signal Transduction and Targeted Therapy, indicates a favourable safety profile and promising antitumour activity. Professor Wang Yongsheng, the lead principal investigator, concluded that CNSI-Fe is effective for treating ferroptosis-sensitive solid tumours, though further evaluation through randomised Phase II/III trials is required.
Written by urgent.news from South China Morning Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
